Published in
American Society of Clinical Oncology, JCO Precision Oncology, 5, p. 1160-1165, 2021
DOI: 10.1200/po.21.00127
Links
Tools
Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma
Journal article published in 2021 by
Angela Mweempwa 
,
Huiling Xu ,
Joseph H. A. Vissers ,
Richard W. Tothill,
Andrew D. Pattison ,
Andrew P. Fellowes ,
David M. Thomas,
Gary Richardson ,
Rodney J. Hicks ,
Sean M. Grimmond ,
Stephen B. Fox ,
Stephen J. Luen ,
Jayesh Desai ,
Benjamin J. Solomon
,
Huiling Xu ,
Joseph H. A. Vissers ,
Richard W. Tothill,
Andrew D. Pattison ,
Andrew P. Fellowes ,
David M. Thomas,
Gary Richardson ,
Rodney J. Hicks ,
Sean M. Grimmond ,
Stephen B. Fox ,
Stephen J. Luen ,
Jayesh Desai ,
Benjamin J. Solomon
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 